SB
Sino Biopharmaceutical Limited
SBHMY · OTC
$13.86 +0.00% (+$0.00)
1M +15.40%
Market Cap ¥77.7B
P/E Ratio 33.15x
Div. Yield 1.97%
ROE 7.32%
Bulios Fair Price
$11.47
17.2% downside
Trenutna cena
$13.86
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SBHMY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
67 /100
Cheap P/E 33.15x
EV/EBITDA 11.22x
P/S 2.44x
Growth
53 /100
Stable EPS growth 2.70%
Rev. growth 5.97%
FCF growth 18.51%
Profitability
87 /100
Strong Gross margin 82.07%
Net margin 7.36%
Op. margin 21.84%
Quality
40 /100
Average ROIC 8.99%
ROE 7.32%
ROA 3.08%
Debt
86 /100
Low Debt/Equity 0.52x
Current ratio 1.37x
Net debt/EBITDA 0.53x
Stability
75 /100
Stable Beta 0.61x
Rev. volatility 4.88%
EPS volatility 66.95%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SBHMY
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
S. Y. Tse
Employees
21,435
Headquarters
Hong Kong